Holen Sie sich die Stockscreener-App
10.38
3.01%
-0.265
Schlusskurs vom Vortag:
$10.65
Offen:
$10.76
24-Stunden-Volumen:
118.07K
Relative Volume:
0.65
Marktkapitalisierung:
$224.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.46M
KGV:
-24.62
EPS:
-0.4218
Netto-Cashflow:
$-34.00M
1W Leistung:
-6.35%
1M Leistung:
-8.99%
6M Leistung:
+151.94%
1J Leistung:
-37.62%
1-Tages-Spanne:
$10.32
$11.30
1-Wochen-Bereich:
$10.32
$11.30
52-Wochen-Spanne:
$3.35
$20.24
Contineum Therapeutics Inc Stock (CTNM) Company Profile
Firmenname
Contineum Therapeutics Inc
Sektor
Branche
Telefon
(858) 333-5280
Adresse
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
Vergleichen Sie CTNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
10.37 | 310.79M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.22 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.22 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.73 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.59 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | Leerink Partners | Outperform |
| 2025-06-20 | Eingeleitet | William Blair | Outperform |
| 2024-10-22 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-30 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-30 | Eingeleitet | Stifel | Buy |
Alle ansehen
Contineum Therapeutics Inc Aktie (CTNM) Neueste Nachrichten
Real time social sentiment graph for Contineum Therapeutics Inc.2025 Growth vs Value & Long-Term Growth Plans - newser.com
Can Contineum Therapeutics Inc. stock outperform in 2025 bull market2025 Market Trends & Expert Curated Trade Ideas - newser.com
Will Contineum Therapeutics Inc. stock benefit from automationWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Is it time to cut losses on Contineum Therapeutics Inc.2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What momentum shifts mean for Contineum Therapeutics Inc.Buy Signal & Reliable Volume Spike Trade Alerts - newser.com
Building trade automation scripts for Contineum Therapeutics Inc.Quarterly Trade Report & Technical Entry and Exit Tips - newser.com
Using Ichimoku Cloud for Contineum Therapeutics Inc. technicalsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
Live market analysis of Contineum Therapeutics Inc.Market Growth Report & Risk Managed Investment Entry Signals - newser.com
Why retail investors pile into Contineum Therapeutics Inc. stockWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Why Contineum Therapeutics Inc. stock could see breakout soonJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
How Contineum Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for Contineum Therapeutics Inc. analyzedBond Market & Fast Entry Momentum Trade Alerts - newser.com
Contineum Therapeutics Inc. stock momentum explained2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
How Contineum Therapeutics Inc. stock compares to growth peersEntry Point & Scalable Portfolio Growth Ideas - newser.com
Volatility clustering patterns for Contineum Therapeutics Inc.July 2025 Breakouts & AI Optimized Trade Strategies - newser.com
Will Contineum Therapeutics Inc. stock split attract more investors2025 Major Catalysts & Consistent Profit Alerts - newser.com
Contineum Therapeutics (NASDAQ:CTNM) Issues Quarterly Earnings Results - MarketBeat
Using data models to predict Contineum Therapeutics Inc. stock movementPortfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities - TipRanks
Is Contineum Therapeutics Inc. building a consolidation baseWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What makes RF Acquisition Corp II stock price move sharply - newser.com
Contineum Therapeutics Reports Increased R&D Investment Amid Losses - TipRanks
Finanzdaten der Contineum Therapeutics Inc-Aktie (CTNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):